Search for: "In re: E.I. DuPont de Nemours and Company"
Results 1 - 20
of 32
Sort by Relevance
|
Sort by Date
21 May 2024, 11:45 am
Relying on and analyzing the “likelihood of confusion” factors set forth in In re E.I. du Pont de Nemours & Co., the TTAB denied ROGUE’s request for cancellation. [read post]
28 Feb 2024, 2:00 pm
(In re Bair Hugger Forced Air Warming Devices Prods.Liab.Litig.) (8th Cir. 2021) 9F.4th 768, 778–780 [concluding it was not unreliable for an expert to rely on a study to draw an inference of causation even though the study found that the association did not establish causation, “so long as the expert does the work ‘to bridge the gap between association and causation’”].) [read post]
29 Mar 2021, 7:10 pm
Some notes on vexing issue, which fortunately has never serious issue for me. [read post]
12 Nov 2020, 5:55 am
“The corporations we’re suing knew full well the potential harms they were inflicting on our environment, but chose to forge ahead anyway. [read post]
15 Oct 2020, 1:01 pm
References [6] In re E.I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (CCPA 1973).[7] In re Mighty Leaf Tea, 601 F.3d 1342, 94 USPQ2d 1257, 1259 (Fed. [read post]
13 Jan 2020, 4:32 pm
In re E.I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563, 567 (CCPA 1973). [read post]
5 Dec 2019, 7:18 am
DU PONT DE NEMOURS AND COMPANY C-8 PERSONAL INJURY LITIGATION, 939 F. [read post]
3 Oct 2018, 2:26 pm
To do so, the Trademark Trial and Appeal Board looks to a 13-part test set forth in the seminal case In re E.I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (CCPA 1973) (the “DuPont Factors”). [read post]
28 Aug 2018, 3:09 pm
In Section 2(d) likelihood of confusion cases, the plaintiff must establish the presence of a likelihood of confusion between the parties’ trademarks pursuant to the thirteen factors set forth in the case of In re E.I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (CCPA 1973). [read post]
28 Jun 2018, 9:44 am
Dupont de Nemours & Co v. [read post]
14 Nov 2016, 9:16 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
22 Mar 2016, 10:22 am
DuPont de Nemours and Company and Corning, Incorporated, as well as an expert on trade secret law, and a professor specializing in trade secret academia. [read post]
27 Sep 2015, 1:54 pm
Du Pont De Nemours & Company (DuPont), for alleged harm from environmental exposure to perfluorooctanoic acid or its salts (PFOA). [read post]
26 May 2015, 7:42 am
SJS/TEN is somewhat analogous in our sandbox to mesothelioma in asbestos cases, since plaintiffs often work backwards from the diagnosis to look for some drug company to sue. [read post]
11 Mar 2014, 8:40 am
In re E.I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (CCPA 1973). [read post]
31 Oct 2013, 5:00 am
DuPont de Nemours & Co., 2008 WL 162156, at *6 (W.D. [read post]
5 Jul 2013, 5:00 am
Thus, in In re Zyprexa Products Liability Litigation, 489 F. [read post]
29 Nov 2012, 1:23 pm
DuPont de Nemours & Co., 851 F. [read post]
14 Mar 2012, 10:19 am
DuPont de Nemours & Co. v. [read post]
4 Aug 2011, 4:02 am
E.I. du Pont de Nemours & Co., No. 719, 2009 (Del. 7/11/11). [read post]
